Open AccessOutcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis
Author(s) -
Don Pham,
Daniel Addison,
Waleed Tallat Kayani,
Arunima Misra,
Hani Jneid,
Jon R. Resar,
Nassir Lakkis,
Mahboob Alam
Publication year - 2018
Publication title -
emergency medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.708
H-Index - 81
eISSN - 1472-0213
pISSN - 1472-0205
DOI - 10.1136/emermed-2017-207065
Subject(s) - medicine , chest pain , meta analysis , beta blocker , anesthesia , medline , emergency medicine , heart failure , political science , law
Beta blockers (β-blockers) remain a standard therapy in the early treatment of acute coronary syndromes. However, β-blocker therapy in patients with cocaine-associated chest pain (CACP) continues to be an area of debate due to the potential risk of unopposed α-adrenergic stimulation and coronary vasospasm. Therefore, we performed a systematic review and meta-analysis of available studies to compare outcomes of β-blocker versus no β-blocker use among patients with CACP.